# Page 1
Administrative approval for procurement of essential drugs and medicines for Blood Pressure and Diabetes for 2018-19 under National Non-Communicable Disease Control Programme.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-0918/ PR No. 453/ A-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
The date: November 5, 2018.
Read: Joint Director (Non-Communicable Diseases), Health Services, Mumbai's letter No. NCD/ 321 1/ Medicine Purchase/ PR/ 2809-10/18, dated 21st August, 2018.
Preamble: National Non-Communicable Diseases Control Programme (NNCDCP), 2018-19
Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke under Project Implementation Programme
Medicines needed for high blood pressure and diabetes
The matter of granting administrative approval for the purchase of medicines was under consideration of the government.
Government Decision: National Cancer Institute under the National Non-Communicable Disease Control Programme by the Central Government.
Diabetes, Heart Disease and Stroke Prevention and Control Programme in 34 districts of the State
can be implemented. Diabetes, Hypertension and Stroke etc. in men and women above 30 years of age.
After the diagnosis, the patient is treated. Treatment of this disease
You need to buy the right medicines. Cost of medicines
Rs. 10,15,14, 072/- (Rupees Ten Crores Fifteen Lakhs Seventy Four Thousand and Seventy Two only) and Hypertension and
# Page 2
Government Resolution No: PRASHAMA-0918/ PR No. 453/ A-7
The medicine is priced at Rs. 4,29,96, 565/- (Rupees Four Crores Thirty-nine Lakhs)
One thousand five hundred and sixty five only) and the purchase of medicines by implementing the tender process in the prescribed manner.
Haffkine Biopharma Corporation Ltd. Available for the year 2018-19.
Administrative approval to purchase medicines for high blood pressure and diabetes within the limits of funds
is being provided.
The details of the drug are as follows:
A-A
--------------------------------------------------------------------------------------------------------
| Sr. No.  | Medicine                   | CS       | DHO      | Total    | Unit Cost | Required Budget |
| A        | B                          | C=A+B    | D        | E=C*D    |
| 1        | Telmisartan Tab 20 mg      | 2287540  | 3336570  | 5624110  | 1.95      | 10967015        |
| 2        | Telmisartan Tab 40 mg      | 3967940  | 5289695  | 9257635  | 3         | 27772905        |
| 3        | Telmisartan Tab 80 mg      | 1494490  | 1279820  | 2774310  | 5.5       | 15258705        |
| 4        | Chlorthalidone Tab 6.25 mg | 1506600  | 1309795  | 2816395  | 3.4       | 9575743         |
| 5        | Chlorthalidone Tab 12.5 mg | 1392600  | 2650760  | 4043360  | 0.7       | 2830352         |
| 6        | Chlorthalidone Tab 25 mg   | 923751   | 2283915  | 3207666  | 1.3       | 4169966         |
| 7        | Glimipiraide 1 mg          | 5167400  | 3885650  | 9053050  | 0.89      | 8057215         |
| 8        | Metformin Tab 500 mg       | 25634565 | 16593430 | 42227995 | 0.273     | 11528243        |
| 9        | Amlodepine tab 5 mg        | 18639745 | 17634405 | 36374150 | 0.133     | 4824462         |
| 10       | Premix Insuline Ing 10 ml  | 20237    | 0        | 20237    | 322.65    | 652968          |
| 11514072 |
--------------------------------------------------------------------------------------------------------
The above medicines are available from the provisions approved under the headings mentioned below
The purchase should be made within the limits of funds.
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. No | FMR Code | Name of Head                               | Available Budget in PIP in 2018-19 (In  |  Lakhs) | Available Budget at State Level for purchase of NPCDCS Medicine (In Lakhs) |
| 1      | 6.2.19.1 | Drugs and Supplies for District NCD Clinic | 329.00                                  | 201.50  |
| 2      | 6.2.19.2 | Drugs and Supplies for CCU/ICU & Cancer    | 10.00                                   | 10.00   |
| 3      | 6.2.19.3 | Drugs and Supplies for CHC NCD             | 684.00                                  | 684.00  |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Page 2 of 5
# Page 3
Government Resolution No: PRASHAMA-0918/ PR No. 453/ A-7
-------------------------------------------------------------------------------------------------------
| Clinic                                |
| 4                                     | 6.2.19.4 | Drugs and Supply for PHC Level | 137.20 | 119.82 |
| Total Budget Available at State Level | 1160.20  | 1015.32                        |
-------------------------------------------------------------------------------------------------------
Appendix-B
----------------------------------------------------------------------------------------------------------
| Sr. No. | Medicine                        | CS      | DHO     | Total    | Unit Cost | Required Budget |
| A       | B                               | C=A+B   | D       | E=C*D    |
| 1       | Glibenclamide Tab 5 mg mg       | 3855354 | 3085740 | 6941094  | 0.165     | 1145281         |
| 2       | Glicaazide Tab 80mg             | 1557820 | 0       | 1557820  | 0.9       | 1402038         |
| 3       | Glipizide Tab 2.5 mg            | 0       | 4160840 | 4160840  | 0.28      | 1165035         |
| 4       | Viglibose Tab 0.2mg             | 1839630 | 0       | 1839630  | 4.9       | 9014187         |
| 5       | Atenelol Tab 50mg               | 8132913 | 6529246 | 14662159 | 0.235     | 3445607         |
| 6       | Enalapril Tab 5 mg              | 3349047 | 5786830 | 9135877  | 1.5       | 13703816        |
| 7       | Losartan Potassium Tab 50mg     | 1847750 |         | 1847750  | 0.36      | 665190          |
| 8       | Metoprolol Tab 50 mg            | 2464271 | 2957940 | 5422211  | 0.356     | 1930307         |
| 9       | Acytyl Salicylic Acid Tab 75 mg | 4418941 | 4664062 | 9083003  | 0.21      | 1907431         |
| 10      | Clopidogrel Tab 75 mg           | 1999047 | 2901220 | 4900267  | 0.769     | 3768305         |
| 11      | Digoxin Tab 0.25 mg             | 324350  | 229020  | 553370   | 0.233     | 128935          |
| 12      | Atorvastatin Tab 10 mg          | 3878930 | 2307145 | 6168075  | 0.35      | 2165126         |
| 13      | Glimipiraide 2 mg               | 8159991 | 6610570 | 14770561 | 0.173     | 2555307         |
| Total   | 42996565                        |
----------------------------------------------------------------------------------------------------------
The above drugs are sold under the heading of FMR Code 6.2.21.1 by NHM Drugs and Services Limited.
The component of Rs. 12791.49 lakhs (Rupees One Hundred and Twenty Seven Crores One Ninety Nine Lakhs
One hundred and fifty thousand only) should be purchased from such provision.
Administrative approval for the purchase of the above medicines subject to the following conditions:
It is provided:
1) Requirement/ demand of these essential medicines and medicines for hypertension and diabetes
This should be verified. After that, to purchase the
Tendering process is going on.
(2) The prescription of such drugs and medicines for hypertension and diabetes as may be required; and
Be sure to check for updates. Technical aspects of the purchase
Technical Specification by the concerned experts (Technical Committee/ Officials)
must be in accordance with the approved specifications. In addition to the technical specifications
Page 3 of 5
# Page 4
Government Resolution No: PRASHAMA-0918/ PR No. 453/ A-7
It should be ensured that the specification is not designed in such a way that it will benefit any particular company. After that, you have to buy them.
(3) The prescribed procurement procedure should be carried out in accordance with the provisions of the revised rule book of procedures for office procurement to be carried out by government departments published under the Government Decision, Industry, Energy and Labor Department, No. 2014/ PR No. 82/ Part-III/ Industry-4, dated December 1, 2016.
4) The rates of the proposed procurement are estimated at the time of granting administrative approval. Therefore, the price should be determined at the end of the purchase process. It should be ensured that the price is less than the market price and not more than the rate at which the supplier has supplied the item to other places.
5) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only the items with proper and correct specifications are purchased.
6) Storage and distribution of the items to be purchased after supply, supply chain management and inventory management should be done in a proper manner to ensure that these items do not remain unused and are used in a timely manner.
7) The purchase should be made according to the government decision, dated 26/07/2017. The expenditure for procurement of these drugs will be met from the grants available under National Health Mission (NHM) approved PIP 2018-19.
8) Also, it should be ensured that there is no duplication in the purchase of these items.
The Central Vigilance Commission (CVC) guidelines should be strictly followed while carrying out the entire procurement process.
30/ Part- 2/2013/ Regulations, dated 17th April, 2015 in Annexure A No. 4 to the Financial Powers Rules, 1978, Part I, Sub-Section-II, Rule No. 7 in front of No. 6 conditions must be met.
Supply orders should be issued only after the approval of the Purchasing Committee after the completion of the procurement process.
Page 4 of 4
# Page 5
Government Resolution No: PRASHAMA-0918/ PR No. 453/ A-7
(3) To fulfil the conditions mentioned in the above-mentioned serial numbers 1 to 11 and according to the rules of purchase and
Commissioner, Health Services and Mission is fully responsible for ensuring that the requirement is met.
Director, National Health Mission, Director, Directorate General of Health Services and Programme Heads
will remain.
Government Resolution, Department of Finance, No. 2013/ No. 30/13/ Regulations, Part II, dated 17
Financial Powers Rules, 1978 Part-I of Sub-Section-II, dated April, 2015
Rule No. 4. 7 Sell tools, spare parts and accessories
Full powers have been delegated to the administrative department to approve the taking
Accordingly, the government has taken the decision.